UK markets closed

Neurocrine Biosciences, Inc. (NBIX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
86.98-0.88 (-1.00%)
At close: 1:00PM EST
86.98 0.00 (0.00%)
After hours: 01:02PM EST
Full screen
Trade prices are not sourced from all markets
Previous close87.86
Open87.80
Bid84.65 x 1400
Ask89.41 x 800
Day's range86.13 - 88.32
52-week range84.50 - 120.27
Volume509,178
Avg. volume641,279
Market cap8.252B
Beta (5Y monthly)0.70
PE ratio (TTM)19.15
EPS (TTM)4.54
Earnings date02 Feb 2022 - 07 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend date29 Dec 1995
1y target est119.40
  • Motley Fool

    Why Neurocrine Biosciences Shares Fell Nearly 10% Today

    Shares of biopharma Neurocrine Biosciences (NASDAQ: NBIX) were down 9.8% in Tuesday's late trading following a disappointing third-quarter report. For the three-month stretch ending in September, Neurocrine turned $296 million in revenue into an operating profit of $0.64 per share. On the basis of generally accepted accounting principles (GAAP), however, profits of only $0.23 per share left the market wanting more, and arguably concerned.

  • Motley Fool

    Neurocrine Biosciences, Inc (NBIX) Q3 2021 Earnings Call Transcript

    NBIX earnings call for the period ending September 30, 2021.

  • Zacks

    Neurocrine Biosciences (NBIX) Lags Q3 Earnings Estimates

    Neurocrine (NBIX) delivered earnings and revenue surprises of -54.90% and 0.48%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?